Mölnlycke Health Care Launches Innovative Wound Care Solutions in the U.S. Market
Mölnlycke Health Care, a recognized leader in the MedTech industry, is advancing its growth trajectory in the United States by introducing three innovative wound care solutions. Since the beginning of 2026, these new products have been designed to improve access to effective wound care options and to establish a stronger presence in the U.S. market. This product launch aligns with the company's commitment to delivering customer-focused innovations, reflecting their dedication to enhancing standards in wound care and patient handling.
The three key products recently made available include the Granudacyn® Wound Wash Solution, the Tortoise® Lite Turning and Positioning System, and the Mepi® Press 2 and Mepi® Press Lite Compression System. Each of these innovations targets the challenges faced by healthcare professionals, especially in light of rising pressures on operations and workforce constraints.
This product serves as a biocompatible and non-cytotoxic wound cleanser, providing a gentle yet effective solution for cleansing both acute and chronic wounds. It is designed to minimize discomfort for patients while simplifying the wound care process for caregivers. With Granudacyn, clinicians can ensure a safe and effective preparation of wounds that is easily integrated into existing care protocols.
The Tortoise® Lite is built with ergonomics in mind, making patient repositioning easier and safer for caregivers. This system is cleverly designed to remain under the patient throughout care, which helps in reducing the physical strain experienced by caregivers, alongside promoting consistent practice in pressure relief. Such features are especially crucial in enhancing patient safety and comfort during treatment.
These compression solutions provide a multi-layer approach to delivering consistent compression therapy, specifically targeting a wide variety of patient needs, including those suffering from venous disease and edema. When combined with Mölnlycke's advanced Mepilex® Up wound dressings and Granudacyn Wound Wash, the Mepi Press systems create a seamless integration into clinical protocols. This synergy is particularly beneficial in managing venous leg ulcers, ultimately improving clinical outcomes for patients and bolstering care delivery for healthcare professionals.
Craig Kennedy, the Vice President of Commercial Wound Care for North America at Mölnlycke, stated, "The year 2026 is pivotal for our strategy as we wish to enhance access to safe, intuitive, and clinically dependable solutions. With these significant product launches, we emphasize our mission to uplift the standard of care while providing healthcare professionals with the necessary tools to make a substantial difference in patient outcomes and care efficiency."
The new offerings from Mölnlycke Health Care are set to be available through the company's U.S. distribution partners, ensuring healthcare providers have ready access to these innovative solutions. For additional information about these products and their applications, interested parties can explore further details on Mölnlycke's official website.
Founded in 1849, Mölnlycke Health Care has dedicated itself to delivering innovative medical technology. Their products support healthcare professionals globally, with solutions tailored to enhance patient outcomes. As they continue to expand in the U.S. market, Mölnlycke's commitment to quality and innovation remains at the forefront of their mission.
The three key products recently made available include the Granudacyn® Wound Wash Solution, the Tortoise® Lite Turning and Positioning System, and the Mepi® Press 2 and Mepi® Press Lite Compression System. Each of these innovations targets the challenges faced by healthcare professionals, especially in light of rising pressures on operations and workforce constraints.
Granudacyn® Wound Wash Solution
This product serves as a biocompatible and non-cytotoxic wound cleanser, providing a gentle yet effective solution for cleansing both acute and chronic wounds. It is designed to minimize discomfort for patients while simplifying the wound care process for caregivers. With Granudacyn, clinicians can ensure a safe and effective preparation of wounds that is easily integrated into existing care protocols.
Tortoise® Lite Turning and Positioning System
The Tortoise® Lite is built with ergonomics in mind, making patient repositioning easier and safer for caregivers. This system is cleverly designed to remain under the patient throughout care, which helps in reducing the physical strain experienced by caregivers, alongside promoting consistent practice in pressure relief. Such features are especially crucial in enhancing patient safety and comfort during treatment.
Mepi® Press 2 and Mepi® Press Lite Compression System
These compression solutions provide a multi-layer approach to delivering consistent compression therapy, specifically targeting a wide variety of patient needs, including those suffering from venous disease and edema. When combined with Mölnlycke's advanced Mepilex® Up wound dressings and Granudacyn Wound Wash, the Mepi Press systems create a seamless integration into clinical protocols. This synergy is particularly beneficial in managing venous leg ulcers, ultimately improving clinical outcomes for patients and bolstering care delivery for healthcare professionals.
Craig Kennedy, the Vice President of Commercial Wound Care for North America at Mölnlycke, stated, "The year 2026 is pivotal for our strategy as we wish to enhance access to safe, intuitive, and clinically dependable solutions. With these significant product launches, we emphasize our mission to uplift the standard of care while providing healthcare professionals with the necessary tools to make a substantial difference in patient outcomes and care efficiency."
The new offerings from Mölnlycke Health Care are set to be available through the company's U.S. distribution partners, ensuring healthcare providers have ready access to these innovative solutions. For additional information about these products and their applications, interested parties can explore further details on Mölnlycke's official website.
Founded in 1849, Mölnlycke Health Care has dedicated itself to delivering innovative medical technology. Their products support healthcare professionals globally, with solutions tailored to enhance patient outcomes. As they continue to expand in the U.S. market, Mölnlycke's commitment to quality and innovation remains at the forefront of their mission.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.